SCHEMBL5483520

SCHEMBL5483520

Cc1cccc(-c2ccnc(N)c2C#N)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.44
NOS2 P35228 3/20 0.44
LMNA P02545 1/20 0.41
NOS1 P29475 1/20 0.41
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 3/20 0.40
HSD17B10 Q99714 3/20 0.39
HPGD P15428 2/20 0.39
ADORA2A P29274 4/20 0.38
ADORA1 P30542 3/20 0.38
LRRK2 Q5S007 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
PRKDC P78527 1/20 0.38
ABL1 P00519 1/20 0.37
PDE10A Q9Y233 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5482017 0.88 LMNA (0.50) NOS3NOS2LMNANOS1KDM4E
SCHEMBL23200373 0.78 CYP1A2 (0.47) LMNAKDM4EALDH1A1HPGDUSP8
SCHEMBL24109599 0.76 KDM4E (0.40) LMNAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL27886224 0.75 MYC (0.40) KDM4EALDH1A1HSD17B10HPGDADORA2A
SCHEMBL27886232 0.75 ALDH1A1 (0.53) KDM4EALDH1A1HSD17B10HPGDADORA2A
SCHEMBL5480724 0.75 ALDH1A1 (0.56) LMNAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL1261198 0.75 NOS2 (0.54) NOS3NOS2LMNANOS1KDM4E
SCHEMBL5483595 0.74 ALDH1A1 (0.45) LMNAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL22675495 0.74 KDM4E (0.36) LMNAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL3205196 0.72 ALDH1A1 (0.59) LMNAKDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K6 NOS3 645/4885NOS2 485/4885LMNA 2130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.